Company: ELV
Filing Date: 2025-10-21
Form Type: 10-Q
Source: 0001156039-25-000136
Chunk: 50

Company: Elevance Health, Inc.
Filing Date: 2025-10-21
Form: 10-Q
Item: Item 8
Chunk 50
---
$(887)$107,921 Product revenue— 15,916 — 15,916 — — 15,916 Service fees5,769 4 594 598 11 — 6,378 Operating revenue - unaffiliated112,695 15,920 2,476 18,396 11 (887)130,215 Operating revenue - affiliated— 10,064 10,716 20,780 312 (21,092)— Operating revenue - total$112,695 $25,984 $13,192 $39,176 $323 $(21,979)$130,215 Benefit expense$93,661 $— $10,409 $10,409 $15 $(10,018)$94,067 Cost of products sold— 23,749 — 23,749 — (10,011)13,738 Operating expense12,998 596 2,101 2,697 1,476 (1,950)15,221 Operating gain (loss)$6,036 $1,639 $682 $2,321 $(1,168)$— $7,189 A reconciliation of reportable segments’ operating revenue to the amounts of total revenues included in our consolidated statements of income for the three and nine months ended September 30, 2025 and 2024 is as follows: Three Months Ended  September 30Nine Months Ended  September 30 2025202420252024Reportable segments’ operating revenue$50,087 $44,719 $148,273 $130,215 Net investment income625 551 1,701 1,524 Net losses on financial instruments(1)(125)(596)(371)Gain (loss) on sale of business— (39)— 201 Total revenues$50,711 $45,106 $149,378 $131,569 

-36-

A reconciliation of reportable segments' operating gain to income before income tax expense included in our consolidated statements of income for the three and nine months ended September 30, 2025 and 2024 is as follows: Three Months Ended  September 30Nine Months Ended  September 30 2025202420252024Income before income tax expense$1,406 $1,373